Drug Shortage Report for BRETYLIUM TOSYLATE INJECTION USP
Report ID | 14644 |
Drug Identification Number | 02185377 |
Brand name | BRETYLIUM TOSYLATE INJECTION USP |
Common or Proper name | BRETYLIUM |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BRETYLIUM TOSYLATE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 5 X 10ML VIALS |
ATC code | C01BD |
ATC description | ANTIARRHYTHMICS, CLASS I AND III |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2017-07-03 |
Estimated end date | 2017-07-28 |
Actual end date | 2017-07-28 |
Shortage status | Resolved |
Updated date | 2017-10-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-10-18 | French | Compare |
v5 | 2017-10-18 | English | Compare |
v4 | 2017-10-18 | French | Compare |
v3 | 2017-10-18 | English | Compare |
v2 | 2017-07-05 | French | Compare |
v1 | 2017-07-05 | English | Compare |
Showing 1 to 6 of 6